FDA: Pharmacy's Other Drugs May be Causing Illness - KTVN Channel 2 - Reno Tahoe News Weather, Video -

FDA: Pharmacy's Other Drugs May be Causing Illness

Posted: Updated:

Health officials have broadened their warning to doctors about other medicines made by a specialty pharmacy linked to a meningitis outbreak.

The Food and Drug Administration took the step Monday because of reports of new illnesses that may be tied to other products made by the same company, the New England Compounding Center of Framingham, Mass.

Now health officials want doctors to contact patients who got any injection made by the company and warn them of the risk of infection.

A steroid made by the pharmacy has been tied to a national outbreak of a rare fungal form of meningitis that has killed 15.

The new reports include meningitis in a patient who got another company steroid and fungal infections in two heart transplant patients.

The potentially contaminated injections were given starting May 21, 2012, with Tennessee so far reporting the most number of overall cases -- 35 cases, including 4 deaths. Other states reporting deaths are Maryland, Michigan and Virginia. Updated case counts can be followed on this link to the CDC's site.

In addition to the states where deaths have occurred, other states with confirmed cases are Florida, Indiana, Minnesota, North Carolina and Ohio.

The CDC says as many as 13,000 people may have received medicine from the potentially contaminated injections.

The company recalled the steroid that was sent to clinics in 23 states, and later recalled everything it makes. (The only Nevada location identified is Sahara Surgery Center in Las Vegas - 702-362-7874)

The Food and Drug Administration is urging anyone who has experienced problems to report it to MedWatch, the agency's voluntary reporting program, by phone at 1-800-FDA-1088 or online at www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm. (AP, CNN)

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and Sarkes Tarzian, Inc. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.